Federal court upholds Medicare drug price negotiation program against Merck's challenge
A federal judge in Washington, D.C., dismissed Merck's lawsuit challenging the Medicare drug price negotiation program, which was filed over three years ago. The ruling by Judge Colleen Kollar-Kotelly marks a significant legal setback for the pharmaceutical industry's efforts to block the Inflation Reduction Act's pricing provisions. The decision allows the negotiation process to proceed as planned.
Related stories
Appeals court breathes new life into Teva's Medicare pricing lawsuit · Healthcare systems
Cytokinetics challenges Bristol Myers Squibb's patent in court · Drug development
TwinStrand wins patent lawsuit, GSK's hepatitis B drug gains Japan approval · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “DC judge rejects Merck’s IRA case more than three years after it was filed.” Browse more stories.